Nabriva to Present at the 2016 Wedbush PacGrow Healthcare Conference
VIENNA, Austria and KING OF PRUSSIA, Pa., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections …